Erick J. Lucera's most recent trade in Dyne Therapeutics Inc was a trade of 2,362 Common Stock done at an average price of $20.4 . Disclosure was reported to the exchange on June 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Erick J. Lucera | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.37 per share. | 25 Jun 2026 | 2,362 | 121,563 | - | 20.4 | 48,114 | Common Stock |
| Dyne Therapeutics Inc | Erick J. Lucera | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.36 per share. | 13 May 2026 | 1,448 | 123,925 | - | 18.4 | 26,585 | Common Stock |
| Dyne Therapeutics Inc | Erick J. Lucera | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.64 per share. | 01 Apr 2026 | 5,727 | 125,373 | - | 18.6 | 106,751 | Common Stock |
| SAB Biotherapeutics Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2025 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 3,750 | 3,750 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2025 | 3,750 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2025 | 2,250 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 2,250 | 2,250 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2025 | 2,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 2,000 | 2,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2025 | 1,500 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 1,500 | 1,500 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2025 | 1,250 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 1,250 | 1,250 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2025 | 1,250 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 1,250 | 1,250 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2025 | 1,250 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 1,250 | 1,250 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2025 | 1,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 1,000 | 1,000 | - | - | Stock Options (Right to buy) | |
| Dyne Therapeutics Inc | Erick J. Lucera | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 214,500 | 214,500 | - | - | Stock Option (Right to Buy) | |
| Dyne Therapeutics Inc | Erick J. Lucera | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 66,100 | 66,100 | - | 0 | Common Stock | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 75,000 | 75,000 | - | - | Stock Options (Right to buy) | |
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 275,100 | 275,100 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.71 per share. | 04 Mar 2025 | 4,109 | 112,720 (0%) | 0% | 1.7 | 7,030 | Common Stock |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 45,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 40,000 | 40,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 40,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 30,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 20,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 20,000 | 20,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Purchase of securities on an exchange or from another person at price $ 0.40 per share. | 14 Aug 2024 | 39,266 | 43,608 (0%) | 0% | 0.4 | 15,565 | Common Stock |
| SAB Biotherapeutics Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | 20 May 2024 | 22,337 | 116,829 (0%) | 0% | 5.6 | 125,404 | Common Stock | |
| Beyond Air Inc | Erick Lucera J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | 02 Mar 2024 | 106,000 | 106,000 | - | - | Stock Option (right to buy) | ||
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | 02 Mar 2024 | 35,300 | 113,200 (0%) | 0% | 0 | Common Stock | ||
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | 02 Mar 2024 | 25,966 | 139,166 (0%) | 0% | 0 | Common Stock | ||
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | 17 May 2023 | 155,800 | 155,800 | - | - | Stock Option (right to buy) | ||
| Editas Medicine Inc | Erick J. Lucera | EVP, CHIEF FINANCIAL OFFICER | 17 May 2023 | 77,900 | 77,900 (0%) | 0% | 0 | Common Stock | ||
| SAB Biotherapeutics Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Purchase of securities on an exchange or from another person at price $ 6.82 per share. | 16 Mar 2023 | 2,000 | 4,342 (0%) | 0% | 6.8 | 13,634 | Common Stock |
| Bone Biologics Corp | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 36,845 | 68,516 | - | - | Non-Employee Stock Option | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |